Profession Pharmacist
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Asymptomatic GBS Bacteriuria During Antenatal Visits: To Treat or Not to Treat?
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: NP0720A-PharmPublished: Jul 2020Expires: 7/31/2023Details -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obesity Treatment: A Focus on Pharmacotherapy of Weight Management
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: ON0320D-PharmPublished: Mar/Apr 2020Expires: 7/31/2023Details -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Mitigating the Dangers of Polypharmacy in Community-Dwelling Older Adults
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: AJN0220B-PharmPublished: February 2020Expires: 7/31/2023DetailsRequired Passing Score: 14/19 (73%)Categories: Geriatrics , Pharmacology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2019, Part 4
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: N1119A-PharmPublished: Nov 2019Expires: 7/31/2023DetailsRequired Passing Score: 14/18 (77%)Categories: Patient Safety , PharmacologySpecialties: Pharmacy, Risk ManagementTopics: Patient Safety -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of GLP-1 Receptor Agonists in Patients with T2DM and Chronic Kidney Disease
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: NP0319BPHPublished: Mar 2019Expires: 3/5/2021DetailsRequired Passing Score: 13/18 (72%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Prescription Opioid Abuse and Addiction: How Can We Curb the Trends? - Vol. 33, No. 5
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM1217PHPublished: April 2019Expires: 4/1/2022DetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Chronic Pain, Impulsivity, and Risk for Opioid Misuse Vol. 33, No. 12
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM0718PHPublished: AprilExpires: 4/1/2022DetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Improving Adherence in Pediatric Chronic Pain: An Introduction to Motivational Interviewing - Vol. 33, No. 10
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM0518PHPublished: April 2019Expires: 4/1/2022DetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Intrathecal Baclofen Infusion: A Treatment for Spasticity and Secondary Generalized Dystonia - Vol. 40, No. 14
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CNE0918BPHPublished: April 2019Expires: 4/1/2022DetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Lenvatinib vs. Sorafenib as First-Line Treatment for Unresectable HCC
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1218PPublished: April 2019Expires: 4/1/2022DetailsRequired Passing Score: 7/10 (70%)